Related Experiment Video
Updated: Sep 6, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
The Therapeutic Potential of Milk Extracellular Vesicles on Colorectal Cancer
Manal A Babaker1,2, Fadwa A Aljoud3, Faris Alkhilaiwi3,4
1Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Abstract:
Colorectal cancer remains one of the leading prevalent cancers in the world and is the fourth most common cause of death from cancer. Unfortunately, the currently utilized chemotherapies fail in selectively targeting cancer cells and cause harm to healthy cells, which results in profound side effects. Researchers are focused on developing anti-cancer targeted medications, which is essential to making them safer, more effective, and more selective and to maximizing their therapeutic benefits. Milk-derived extracellular vesicles (EVs) from camels and cows have attracted much attention as a natural substitute product that effectively suppresses a wide range of tumor cells. This review sheds light on the biogenesis, methods of isolation, characterization, and molecular composition of milk EVs as well as the therapeutic potentials of milk EVs on colorectal cancer.
Insights
Milk extracellular vesicles (EVs) show promise as a targeted therapy for colorectal cancer, offering a safer alternative to traditional chemotherapy by suppressing tumor cells with fewer side effects.
Area of Science:
- Oncology
- Biotechnology
- Nanomedicine
Background:
- Colorectal cancer is a leading cause of cancer death globally.
- Current chemotherapies lack selectivity, harming healthy cells and causing severe side effects.
- Targeted therapies are crucial for improving cancer treatment efficacy and safety.
Purpose of the Study:
- To review the biogenesis, isolation, and characterization of milk-derived extracellular vesicles (EVs).
- To explore the therapeutic potential of milk EVs, particularly in the context of colorectal cancer.
- To highlight milk EVs as a natural and selective anti-cancer agent.
Main Methods:
- Literature review on milk EV research.
- Analysis of studies detailing EV biogenesis and isolation techniques.
- Examination of research on the anti-tumor effects of milk EVs.
Main Results:
- Milk EVs from various sources, including camels and cows, demonstrate significant tumor-suppressive properties.
- These EVs can be isolated and characterized using established methods.
- The molecular composition of milk EVs contributes to their targeted therapeutic effects.
Conclusions:
- Milk-derived EVs represent a promising natural product for developing targeted colorectal cancer therapies.
- Their selective action against tumor cells offers a potential advantage over conventional chemotherapy.
- Further research into milk EVs could lead to more effective and safer cancer treatments.
Related Concept Videos
Mesenchymal Stem Cells
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

